IPO Key Dates
Anchor Investor Subscription | Â |
IPO opens on | 29 Sept. 2025 |
IPO Closes on | 1 Octo 2025 |
Allotment on | 3 Octo. 2025 |
Credit of shares on | 6 Octo. 2025 |
Tentative Listing on | 7 Octo.2025 |
Registered office in.. |
Mumbai Maharastra Email-Â investors@vijaypdceutical.com |
Lead Manager of the IPO |
Smart Horizon Capital Advisors Pvt ltd |
Registrar to the IPO |
Kfin Technologies ltd |
Business:
Incorporated in October 1971, Vijaypd Ceutical Limited is engaged in distribution of pharmaceutical products and consumer goods, with a wide service range as representatives, dealers, agents, stockists, suppliers, traders, and packers. The company caters to pharmaceuticals, wellness and FMCG markets, covering medicines, vitamins, hormones, enzymes, ayurvedic products, cosmetics, diagnostics, baby care, sanitizers and personal care. As on March 31, 2025, it serves over 2,109 pharmacies, clinics and nursing homes across 20 locations in four districts. Its strong distribution network connects with more than 170 healthcare manufacturers and gives access to over 19,000 SKUs. Backed by FDA, FSSAI and BMC certifications, the company ensures quality and reliability in its supply chain.
IPO Details
 | |
IPO opens on | 29 September 2025 |
IPO closes on | 1 October 2025 |
Issue Type | Book Built Issue IPO |
Issue Size | 55,00,000 Shares / Rs 19.25 Crore |
* Fresh Issue | – |
* Offer for Sale – | – |
Market Maker Portion | 2,84,000 Shares |
Net offer to Public | 52,16,000 Shares Rs. 18.26 Crores |
Face Value per share | Rs. 10 |
Price Band | Rs. 35 |
Employee discount | Rs. 0 per share |
Retail Lot Size | 4000 Shares |
Listing will at | NSE SME |
How shares are being offered
Investor Category | Shares Offered |
Market Maker | 5.16% |
NII (HNI)Â | 47.42% |
Retail Shares Offered | 47.42% |
Total Shares | 100.00% |
Application | Shares | Amount |
Retail (Min) | 8,000 | 2,80,000 |
Retail (Max) | 8,000 | 2,80,000 |
HNI (Min) | 12,000 | 4,20,000 |
Â
The Promoters’ Holding
The promoters hold 78.30% of the pre-IPO capital
The Objects of the IPO
The Company proposes to utilize the Net Proceeds from Issue towards funding the following objects
Objects of the Issue | ₹ in crores |
Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra | 10.83 |
Repayment/prepayment of all or certain of the borrowings availed of by the Company | 5.1 |
General corporate purposes | 0.7 |
Financials Snapshot
Period Ended | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
Assets | 57.15 | 33.27 | 32.87 |
Total Income | 107.59 | 54.34 | 50.59 |
Profit After Tax | 4.8 | 1.65 | 0.18 |
EBITDA | 8.59 | 4.87 | 1.32 |
NET Worth | 32.17 | 1 | 4.93 |
Reserves and Surplus | 18.14 | Â | Â |
Total Borrowing | 21.77 | 30.04 | 25.56 |
Amount in ₹ Crore |
Â
Peer Comparison:
Key Financial Indicators
KPI | Values |
ROE | 28.91% |
ROCE | 17.30% |
Debt/Equity | 0.68 |
RoNW | 14.91% |
PAT Margin | 4.49% |
EBITDA Margin | 8.04% |
IPO REcommendation/Concise Review-
So-So
Quicklinks
- Market Analysis by Nagaraj Shetti
- Stock Market today by Vaishali Parekh
- Analysis by Kotak Securities
- Market Analysis by HDFC Securities
- Technical Analysis by Kotak Securities
- Technical Analysis by Samco Securities
- Reliance, Target & Stoploss
- Gold Analysis
- FII buy-Sell
- Technical AnalysisÂ
- Calls for the Day
- Currency Analysis
# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.